Zacks Small Cap Research on MSN54m
AEMD: Oncology Trial Moves Forward as Patient Enrollments Begin, Positive on Cost Containment MeasuresAEMD READ THE FULL AEMD RESEARCH REPORT Patient enrollments begin for AEMD’s basket oncology trial Aethlon Medical (NASDAQ:AEMD) announced FY 2Q results and provided a business update yesterday. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback